Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merck & Company (GB:0QAH)
LSE:0QAH
Merck & Company (0QAH) Share Price & Analysis
4 Followers
0QAH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$97.81 - $133.08
Previous Close$127.8
Volume2.47K
Average Volume (3M)207.49K
Market Cap
$322.94B
Enterprise Value$351.60B
Total Cash (Recent Filing)$5.62B
Total Debt (Recent Filing)$34.22B
Price to Earnings (P/E)142.3
Beta0.37
Next Earnings
Jul 30, 2024EPS Estimate
$2.13Last Dividend Ex-Date
Mar 14, 2024Dividend Yield2.35%
Share Statistics
EPS (TTM)0.90
Shares Outstanding2,532,643,872
10 Day Avg. Volume47,622
30 Day Avg. Volume207,485
Standard Deviation0.05
R-Squared0.05
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-198.49
Price to Sales (P/S)12.35
Price to Cash Flow (P/CF)328.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.73
Enterprise Value/Gross Profit7.99
Enterprise Value/Ebitda44.77
Forecast
1Y Price Target
$139.07Price Target Upside8.82% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
Merck & Company News
Bulls Say, Bears Say
Bulls Say
Financial GuidanceMerck's increase and narrowing of FY24 guidance for revenue and non-GAAP EPS indicates strong financial performance.
Pipeline DevelopmentUpcoming FDA decisions on Merck's products could extend gains for the company, showing potential for further expansion in oncology and vaccines.
Product Portfolio ExpansionWith new launches in cardiovascular and vaccines, focus is moving away from a single-product reliance, showing diversification.
Bears Say
Financial PerformanceVAXNEUVANCE 4Q23 sales were $176 mln - below Mizuho and Bloomberg estimates.
Product PricingMerck disclosed $14K/vial pricing for Winrevair, with flat pricing across 45mg and 60mg doses at maintenance dosing of 0.7mg/kg, which is modestly below the $250-300K where the Street had anchored.
Research And DevelopmentMerck did a substantial pruning of their oncology pipeline, including several indications and treatments.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.16% Insiders
21.82% Mutual Funds
23.04% Other Institutional Investors
54.98% Public Companies and
Individual Investors
0QAH FAQ
What was Merck & Company’s price range in the past 12 months?
Merck & Company lowest share price was $97.81 and its highest was $133.08 in the past 12 months.
What is Merck & Company’s market cap?
Currently, no data Available
When is Merck & Company’s upcoming earnings report date?
Merck & Company’s upcoming earnings report date is Jul 30, 2024 which is in 85 days.
How were Merck & Company’s earnings last quarter?
Merck & Company released its earnings results on Apr 25, 2024. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.886 by $0.184.
Is Merck & Company overvalued?
According to Wall Street analysts Merck & Company’s price is currently Undervalued.
Does Merck & Company pay dividends?
Merck & Company pays a Quarterly dividend of $0.77 which represents an annual dividend yield of 2.35%. See more information on Merck & Company dividends here
What is Merck & Company’s EPS estimate?
Merck & Company’s EPS estimate is $2.13.
How many shares outstanding does Merck & Company have?
Merck & Company has 2,532,643,800 shares outstanding.
What happened to Merck & Company’s price movement after its last earnings report?
Merck & Company reported an EPS of $2.07 in its last earnings report, beating expectations of $1.886. Following the earnings report the stock price went up 2.052%.
Which hedge fund is a major shareholder of Merck & Company?
Among the largest hedge funds holding Merck & Company’s share is Fisher Asset Management LLC. It holds Merck & Company’s shares valued at 1B.
---
Merck & Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$139.07 (8.82% Upside)
$139.07 (8.82% Upside)
Blogger Sentiment
Bullish
GB:0QAH Sentiment 93%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $36.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.80%
12-Months-Change
Fundamentals
Return on Equity
5.29%
Trailing 12-Months
Asset Growth
-1.81%
Trailing 12-Months
Company Description
Merck & Company
Merck & Co., Inc. develops pharmaceutical and vaccine products. It also offers healthcare solutions and vaccines addressing animal health. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
---
0QAH Company Deck
---
0QAH Earnings Call
Q1 2024
0:00 / 0:00
---
0QAH Sales Breakdown
45.91% Oncology
22.09% Vaccines
5.64% Hospital Acute Care
5.60% Diabetes
20.75% Other
---
0QAH Stock 12 Months Forecast
Average Price Target
$139.07
▲(8.82% Upside)
Technical Analysis
Best Analysts Covering 0QAH
1 Year
1 Year Success Rate
19/20 ratings generated profit
1 Year Average Return
+16.52%
reiterated a buy rating 12 days ago
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 95.00% of your transactions generating a profit, with an average return of +16.52% per trade.
---